qGenEx® WES
whole exome sequencing
Since 2011, when we started offering NGS analysis to our collaborators, it was clear to us that the complete exome sequencing (WES) represents the most reliable and cost-efficient option to reach a diagnosis, both at the time of sequencing and over the years.
We use Illumina’s sequencing technology and guarantee an average coverage >50x
and for more than 95% of the coding regions a coverage >15x
Sequencing of the complete exome adapted to every needs:
Raw sequence data in FASTQ format and quality data analysis
Basic Service + full report with annotation and prioritization of variants
Research Service + validation of findings + segregation study